SafeGuard Surgical Receives FDA “Breakthrough” Designation, Secures Funding from Tom Pepin and NFL QB Jameis Winston
Tampa, FL, March 14, 2024 (GLOBE NEWSWIRE) — SafeGuard Surgical, a leading medical technology company focused on life-saving biodegradable solutions, announced today a major milestone in its mission to improve global healthcare. The U.S. Food and Drug Administration (FDA) has... Read More →
RealSeq Biosciences Extends Seed Funding
RealSeq Biosciences, Inc., a Santa Cruz, CA-based biotechnology company focused on RNA-based diagnostics, extended its Seed funding. The round was led by new investors Charleston Angel Partners, Santa Clara Ventures, and Santa Cruz Ventures, with participation from earlier investors. Read... Read More →
ChestPal™ Pro, a Bluetooth-Connected, Portable, Crackle and Wheeze Detection Innovation, Launches in the U.S. as Early Asthma and Allergy Season Looms
New Digital Stethoscope Detects and Classifies Subtle Lung Sounds, Aiding Healthcare Pros in Diagnosis and Patient Management ATLANTA–(BUSINESS WIRE)–ChestPal™ Pro, the only commercially available digital stethoscope in the U.S. that’s clinically backed to detect, classify, record, and share crackles and... Read More →
Novel ultrasound device gets FDA breakthrough designation with Children’s National support
A novel ultrasound device developed by Bloom Standard received the Food and Drug Administration’s valued breakthrough device designation with the help of Children’s National Hospital and support provided through an FDA-funded grant that established the Alliance for Pediatric Device Innovation... Read More →
Gradient Denervation Technologies Enrolls First Patient in Early Feasibility Study of Pulmonary Artery Denervation System
FDA-Approved US study intended to evaluate pulmonary artery denervation in heart failure patients with WHO Group 2 Pulmonary Hypertension PARIS, March 6, 2024 /PRNewswire/ — Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-based device designed to... Read More →
Bloomlife and Valley Perinatal Services Partner to Transform High-Risk Maternal Care
SAN FRANCISCO, March 5, 2024 /PRNewswire/ — Bloomlife, an award winning women’s health company, and Valley Perinatal Services (VPS), Arizona’s leading high-risk maternal fetal medicine group, today announced a commercial partnership along with results from the initial deployment of Bloomlife’s... Read More →
Bone Health Technologies Raises $5M to Advance Osteopenia Treatment
Bone Health Technologies (BHT) has recently closed a $5 million funding round to enhance care for individuals with low bone density. This round saw contributions from Esplanade Ventures, Berkeley Catalyst Fund, and Terumo Medical, a global leader in medical technology. The... Read More →
Phagenesis raises $42m to take medical device for swallowing disorders to the US
The startup received FDA clearance for its medical device in the US in 2022 and is now looking to commercialise its product in the country K medtech startup Phagenesis has raised a $42m Series D to roll out its medical... Read More →
Augment Health announces investment from Vanderbilt University as part of latest funding round
Augment Health, Inc., a medical technology company developing next generation urologic monitoring tools for patients with chronic conditions, recently announced an investment from Vanderbilt University’s Innovation Investment Committee (“IIC”). The IIC investment follows milestones the company achieved in 2023, including:... Read More →
EpiCypher Partners With Bioz to Facilitate High-Quality Research by Displaying Scientific Product Citations
PALO ALTO, Calif., February 28, 2024 (Newswire.com) – Bioz, Inc., a leading AI software company committed to advancing scientific discovery, is pleased to spotlight its strategic partnership with EpiCypher, a prominent player in the realm of epigenetics and chromatin science. Through this... Read More →